您的位置: 首页 > 农业专利 > 详情页

METHOD FOR USING EXPRESSION OF KLK2 TO DETERMINE PROGNOSIS OF PROSTATE CANCER
专利权人:
INC.;GENOMIC HEALTH
发明人:
BAEHNER, FREDERICK L.,BAKER, JOFFRE B.,CHERBAVAZ, DIANA,COWENS, WAYNE,CRAGER, MICHAEL,GODDARD, AUDREY,KIEFER, MICHAEL C.,LEE, MARK,MADDALA, TARA,PELHAM, ROBERT J.,SHAK, STEVEN
申请号:
CA3081061
公开号:
CA3081061A1
申请日:
2011.07.25
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
Molecular assays that involve measurement of expression levels of prognostic biomarkers, or co-expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for said patient, and likelihood that said patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status, are provided herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充